Website
N/ATelephone
61.8.6465.5500
Address
Suite 1 245 Churchill Avenue Subiaco, Western Australia (WA) 6008
Description
EVE Health Group Ltd. engages in the development and provision of health and wellness solutions. Its portfolio includes Omni Innovation, Meluka Australia, Jenbrook Australia, and Naturally Australian Products. It operates through the following segments: Jenbrook, Meluka, and Investment. The company was founded on October 1, 2003 and is headquartered in Subiaco, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
AU$311.00
1 week
0%
1 month
0%
YTD
-33.33%
1 year
0%
All time high
0.212943
EPS 3 yr Growth
33.300%
EBITDA Margin
-90.80%
Operating Cashflow
-$2m
Free Cash Flow Return
-31.50%
ROIC
-44.90%
Interest Coverage
N/A
Quick Ratio
3.60
Shares on Issue (Fully Dilluted)
5274m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 May 17 |
Investor Presentation
×
Investor Presentation |
31 July 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 January 23 |
Appendix 4C - December Quarter 2022
×
Appendix 4C - December Quarter 2022 |
31 January 22 |
Appendix 4C - December Quarter 2021
×
Appendix 4C - December Quarter 2021 |
31 August 22 |
Appendix 4E and Preliminary Final Report
×
Appendix 4E and Preliminary Final Report |
31 August 21 |
2021 Annual Report
×
2021 Annual Report |
31 August 20 |
2020 Annual Report
×
2020 Annual Report |
30 September 22 |
Director Resignation
×
Director Resignation |
30 September 22 |
Date of AGM and Closing Date for Director Nominations
×
Date of AGM and Closing Date for Director Nominations |
30 October 06 |
Annual Report
×
Annual Report |
30 November 06 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
30 May 22 |
Proposed issue of securities - EVE
×
Proposed issue of securities - EVE |
30 May 22 |
Non-Renounceable Rights Offer
×
Non-Renounceable Rights Offer |
30 May 22 |
Cleansing Notice
×
Cleansing Notice |
30 May 22 |
Letter to Optionholders
×
Letter to Optionholders |
30 June 22 |
Director Resignation and Appendix 3Z
×
Director Resignation and Appendix 3Z |
30 August 23 |
Appendix 4E - Results for Announcement to the Market
×
Appendix 4E - Results for Announcement to the Market |
29 September 23 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 September 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
29 October 08 |
Annual Report 2008
×
Annual Report 2008 |
29 October 07 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
29 November 05 |
Energy Ventures Limited - AGM Presentation
×
Energy Ventures Limited - AGM Presentation |
29 April 22 |
Appendix 4C - March Quarter 2022
×
Appendix 4C - March Quarter 2022 |
28 October 13 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
28 October 13 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 November 07 |
AGM Presentation November 2007
×
AGM Presentation November 2007 |
28 June 22 |
Change of Director's Interest Notice x 3
×
Change of Director's Interest Notice x 3 |
28 June 22 |
Becoming a substantial holder
×
Becoming a substantial holder |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.